Sharing best practice in diabetes care: Focus on the patient with longstanding type 2 diabetes mellitus

shutterstock_2572561987 - image for home page

This article presents experts' view of three clinical scenarios where intensification of T2DM treatment is required

Learning objectives

You will learn:

  • The role of basal insulin and glucagon-like peptide-1 receptor agonists (GLP-1RAs) as described in current guidelines
  • The benefits of a GLP-1RA vs a prandial insulin as an add-on to a basal insulin
  • How to initiate and titrate fixed-ratio basal insulin and GLP-1RA fixed-ratio combinations (FRCs)
  • What is overbasalisation in type 2 diabetes
  • The FRCs of basal insulin and GLP-1RAs available in South Africa.
ATTENTIONKindly note that if you attended the live webinar, you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record 1 CPD point from the live webinar, invalidating any additional CPD points from the report.Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don't upload these yourself.

To access this module, please register or login: